Literature DB >> 29029734

3D lung spheroid cultures for evaluation of photodynamic therapy (PDT) procedures in microfluidic Lab-on-a-Chip system.

Agnieszka Zuchowska1, Elzbieta Jastrzebska2, Michal Chudy1, Artur Dybko1, Zbigniew Brzozka1.   

Abstract

The purpose of this paper is to present a fully integrated microchip for the evaluation of PDT procedures efficiency on 3D lung spheroid cultures. Human lung carcinoma A549 and non-malignant MRC-5 spheroids were utilized as culture models. Spheroid viability was evaluated 24 h after PDT treatment, in which 5-aminolevulinic acid (ALA) had been used as a precursor of a photosensitizer (protoporphyrin IX - PpIX). Moreover, spheroid viability over a long-term (10-day) culture was also examined. We showed that the proposed PDT treatment was toxic only for cancer spheroids. This could be because of a much-favoured enzymatic conversion of ALA to PpIX in cancer as opposed normal cells. Moreover, we showed that to obtain high effectiveness of ALA-PDT on lung cancer spheroids additional time of spheroid after light exposure was required. It was found that PDT had been effective 5 days after PDT treatment with 3 mM ALA. To the best of our knowledge this has been the first presentation of such research performed on a 3D lung spheroids culture in a microfluidic system.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3D culture model; Lung cells; Photocytotoxicity; Photodynamic therapy (PDT); Reactive oxygen species; Spheroids

Mesh:

Substances:

Year:  2017        PMID: 29029734     DOI: 10.1016/j.aca.2017.07.009

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  8 in total

1.  An Air Bubble-Isolating Rotating Wall Vessel Bioreactor for Improved Spheroid/Organoid Formation.

Authors:  Michael A Phelan; Anthony L Gianforcaro; Jonathan A Gerstenhaber; Peter I Lelkes
Journal:  Tissue Eng Part C Methods       Date:  2019-08       Impact factor: 3.056

Review 2.  A Decade of Organs-on-a-Chip Emulating Human Physiology at the Microscale: A Critical Status Report on Progress in Toxicology and Pharmacology.

Authors:  Mario Rothbauer; Barbara E M Bachmann; Christoph Eilenberger; Sebastian R A Kratz; Sarah Spitz; Gregor Höll; Peter Ertl
Journal:  Micromachines (Basel)       Date:  2021-04-21       Impact factor: 2.891

3.  Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapy.

Authors:  Else Driehuis; Sacha Spelier; Irati Beltrán Hernández; Remco de Bree; Stefan M Willems; Hans Clevers; Sabrina Oliveira
Journal:  J Clin Med       Date:  2019-11-05       Impact factor: 4.241

Review 4.  Challenges of applying multicellular tumor spheroids in preclinical phase.

Authors:  Se Jik Han; Sangwoo Kwon; Kyung Sook Kim
Journal:  Cancer Cell Int       Date:  2021-03-04       Impact factor: 5.722

5.  Fingerprinting Metabolic Activity and Tissue Integrity of 3D Lung Cancer Spheroids under Gold Nanowire Treatment.

Authors:  Hadi Hashemzadeh; Ali Hamad Abd Kelkawi; Abdollah Allahverdi; Mario Rothbauer; Peter Ertl; Hossein Naderi-Manesh
Journal:  Cells       Date:  2022-01-29       Impact factor: 6.600

6.  Phototherapeutic Induction of Immunogenic Cell Death and CD8+ T Cell-Granzyme B Mediated Cytolysis in Human Lung Cancer Cells and Organoids.

Authors:  Asta Valančiūtė; Layla Mathieson; Richard A O'Connor; Jamie I Scott; Marc Vendrell; David A Dorward; Ahsan R Akram; Kevin Dhaliwal
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

7.  Lung carcinoma spheroids embedded in a microfluidic platform.

Authors:  Ece Yildiz-Ozturk; Pelin Saglam-Metiner; Ozlem Yesil-Celiktas
Journal:  Cytotechnology       Date:  2021-04-22       Impact factor: 2.040

8.  Characterising a PDMS based 3D cell culturing microfluidic platform for screening chemotherapeutic drug cytotoxic activity.

Authors:  M Ibrahim Khot; Mark A Levenstein; Greg N de Boer; Gemma Armstrong; Thomas Maisey; Hafdis S Svavarsdottir; Helen Andrew; Sarah L Perry; Nikil Kapur; David G Jayne
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.